VenoStent

VenoStent is a tissue engineering medical device company developing bioabsorbable polymer wraps for better outcomes in vascular surgery.

Funding reportedLast round: Series A

Advanced MaterialsHouston, United States

What company datasets say VenoStent raised

Funding, as reported

Reported in all$30Min dollars

Rounds12

Last roundSeries A

Last round dateJun 2024

Investors listed20

SEC Form D$29M sold, 6 filings, last May 2026

Y CombinatorS20

From VenoStent's own website: 1 founder, 3 on the team.

Geoff LucksCOO & Co-founder

Investors who name them

Each firm lists VenoStent on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Startups like it

Add your raise, your deck and your story, and put VenoStent in front of investors. Or tell us what we have wrong.